Company intelligence / Profile preview

Medcolcanna Organics

Canada

Ownership: Private
Development stage: Other

Overview

Medcolcanna Organics is a Canadian integrated medical cannabis company with operations in Colombia, listed on the CSE (MCCN). It employs a vertically integrated model to produce pharmaceutical-grade cannabis flowers, extracts, distillates, isolates, and APIs for export. The company is collaborating with the University of Groningen on clinical trials for 12 cannabis formulations targeting various medical conditions.

Therapeutic areas: OncologyNeurology
Modalities: Small moleculeCannabis-derived products
Industry: Biotech

Partnerships

University of Groningen (clinical trials)Pharmaceutical partnerships globally

Beyond the preview

Go deeper on Medcolcanna Organics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medcolcanna Organics.

Explore the full profile